OCT4: Dynamic DNA binding pioneers stem cell pluripotency

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 3, 2014, Pages 138-154

  Jerabek, Stepan ^a   Merino, Felipe ^a   Schöler, Hans Robert ^a   Cojocaru, Vlad ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

Author keywords

Cellular pluripotency; Combinatorial control of transcription; Cooperative DNA binding; OCT4 (POU5F1); Pioneer transcription factor; POU family

Indexed keywords

DNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR;

ALTERNATIVE RNA SPLICING; CELL FATE; CELL LINEAGE; CHROMATIN; DNA BINDING; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GASTRULATION; GENE CONTROL; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; GERMLINE STEM CELL; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY SEQUENCE; REVIEW; SOMATIC CELL;

ANIMALIA;

CELLULAR PLURIPOTENCY; COMBINATORIAL CONTROL OF TRANSCRIPTION; COOPERATIVE DNA BINDING; OCT4 (POU5F1); PIONEER TRANSCRIPTION FACTOR; POU FAMILY;

ANIMALS; CELL DIFFERENTIATION; DNA; GENE EXPRESSION REGULATION; HUMANS; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; RESPONSE ELEMENTS;

EID: 84896711662     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2013.10.001     Document Type: Review

References (244)

1. Tantin D. Oct transcription factors in development and stem cells: insights and mechanisms. Development 2013, 140:2857-2866.
2. Zhao F.Q. Octamer-binding transcription factors: genomics and functions. Front. Biosci. (Landmark Ed) 2013, 18:1051-1071.
3. Lenardo M.J., Staudt L., Robbins P., Kuang A., Mulligan R.C., Baltimore D. Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor. Science 1989, 243:544-546.
4. Okamoto K., Okazawa H., Okuda A., Sakai M., Muramatsu M., Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 1990, 60:461-472.
5. Schöler H.R., Hatzopoulos A.K., Balling R., Suzuki N., Gruss P. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J. 1989, 8:2543-2550.
6. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Schöler H., Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998, 95:379-391.
7. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24:372-376.
8. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
9. Ambrosetti D.C., Basilico C., Dailey L. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol. Cell. Biol. 1997, 17:6321-6329.
10. Botquin V., Hess H., Fuhrmann G., Anastassiadis C., Gross M.K., Vriend G., Schöler H.R. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev. 1998, 12:2073-2090.
11. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., Guenther M.G., Kumar R.M., Murray H.L., Jenner R.G., Gifford D.K., Melton D.A., Jaenisch R., Young R.A. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
12. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., Wong E., Orlov Y.L., Zhang W., Jiang J., Loh Y.H., Yeo H.C., Yeo Z.X., Narang V., Govindarajan K.R., Leong B., Shahab A., Ruan Y., Bourque G., Sung W.K., Clarke N.D., Wei C.L., Ng H.H. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
13. Kim J., Chu J., Shen X., Wang J., Orkin S.H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008, 132:1049-1061.
14. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., Bourque G., George J., Leong B., Liu J., Wong K.Y., Sung K.W., Lee C.W., Zhao X.D., Chiu K.P., Lipovich L., Kuznetsov V.A., Robson P., Stanton L.W., Wei C.L., Ruan Y., Lim B., Ng H.H. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 2006, 38:431-440.
15. Nishimoto M., Fukushima A., Okuda A., Muramatsu M. The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol. Cell. Biol. 1999, 19:5453-5465.
16. Ouyang Z., Zhou Q., Wong W.H. ChIP-Seq of transcription factors predicts absolute and differential gene expression in embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:21521-21526.
17. Soufi A., Donahue G., Zaret K.S. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 2012, 151:994-1004.
18. Ho L., Jothi R., Ronan J.L., Cui K., Zhao K., Crabtree G.R. An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5187-5191.
19. Singhal N., Graumann J., Wu G., Arauzo-Bravo M.J., Han D.W., Greber B., Gentile L., Mann M., Schöler H.R. Chromatin-remodeling components of the baf complex facilitate reprogramming. Cell 2010, 141:943-955.
20. Ding J., Xu H., Faiola F., Ma'ayan A., Wang J. Oct4 links multiple epigenetic pathways to the pluripotency network. Cell Res. 2012, 22:155-167.
21. Esch D., Vahokoski J., Groves M.R., Pogenberg V., Cojocaru V., Vom Bruch H., Han D., Drexler H.C., Arauzo-Bravo M.J., Ng C.K., Jauch R., Wilmanns M., Schöler H.R. A unique Oct4 interface is crucial for reprogramming to pluripotency. Nat. Cell Biol. 2013, 15:295-301.
22. Pardo M., Lang B., Yu L., Prosser H., Bradley A., Babu M.M., Choudhary J. An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 2010, 6:382-395.
23. van den Berg D.L., Snoek T., Mullin N.P., Yates A., Bezstarosti K., Demmers J., Chambers I., Poot R.A. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell 2010, 6:369-381.
24. Rosner M.H., Vigano M.A., Ozato K., Timmons P.M., Poirier F., Rigby P.W., Staudt L.M. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990, 345:686-692.
25. Sabour D., Schöler H.R. Reprogramming and the mammalian germline: the Weismann barrier revisited. Curr. Opin. Cell Biol. 2012, 24:716-723.
26. Schöler H.R., Ruppert S., Suzuki N., Chowdhury K., Gruss P. New type of POU domain in germ line-specific protein Oct-4. Nature 1990, 344:435-439.
27. Schöler H.R., Dressler G.R., Balling R., Rohdewohld H., Gruss P. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J. 1990, 9:2185-2195.
28. Yeom Y.I., Ha H.S., Balling R., Schöler H.R., Artzt K. Structure, expression and chromosomal location of the Oct-4 gene. Mech. Dev. 1991, 35:171-179.
29. Naiche L.A., Harrelson Z., Kelly R.G., Papaioannou V.E. T-box genes in vertebrate development. Annu. Rev. Genet. 2005, 39:219-239.
30. Krishnan B.R., Jamry I., Chaplin D.D. Feature mapping of the HLA class I region: localization of the POU5F1 and TCF19 genes. Genomics 1995, 30:53-58.
31. Takeda J., Seino S., Bell G.I. Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res. 1992, 20:4613-4620.
32. Nordhoff V., Hubner K., Bauer A., Orlova I., Malapetsa A., Schöler H.R. Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences. Mamm. Genome 2001, 12:309-317.
33. Okazawa H., Okamoto K., Ishino F., Ishino-Kaneko T., Takeda S., Toyoda Y., Muramatsu M., Hamada H. The oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer. EMBO J. 1991, 10:2997-3005.
34. Müller F., Tora L. Chromatin and DNA sequences in defining promoters for transcription initiation. Biochim. Biophys. Acta, Gene Regul. Mech. 2013, 1839:118-128. (in this issue).
35. Minucci S., Botquin V., Yeom Y.I., Dey A., Sylvester I., Zand D.J., Ohbo K., Ozato K., Schöler H.R. Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo. EMBO J. 1996, 15:888-899.
36. Sylvester I., Schöler H.R. Regulation of the Oct-4 gene by nuclear receptors. Nucleic Acids Res. 1994, 22:901-911.
37. Ben-Shushan E., Sharir H., Pikarsky E., Bergman Y. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells. Mol. Cell. Biol. 1995, 15:1034-1048.
38. Pikarsky E., Sharir H., Ben-Shushan E., Bergman Y. Retinoic acid represses Oct-3/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region. Mol. Cell. Biol. 1994, 14:1026-1038.
39. Schoorlemmer J., van Puijenbroek A., van Den Eijnden M., Jonk L., Pals C., Kruijer W. Characterization of a negative retinoic acid response element in the murine Oct4 promoter. Mol. Cell. Biol. 1994, 14:1122-1136.
40. Gu P., LeMenuet D., Chung A.C., Mancini M., Wheeler D.A., Cooney A.J. Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation. Mol. Cell. Biol. 2005, 25:8507-8519.
41. Sato N., Kondo M., Arai K. The orphan nuclear receptor GCNF recruits DNA methyltransferase for Oct-3/4 silencing. Biochem. Biophys. Res. Commun. 2006, 344:845-851.
42. Tesar P.J., Chenoweth J.G., Brook F.A., Davies T.J., Evans E.P., Mack D.L., Gardner R.L., McKay R.D. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448:196-199.
43. Yeom Y.I., Fuhrmann G., Ovitt C.E., Brehm A., Ohbo K., Gross M., Hubner K., Schöler H.R. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 1996, 122:881-894.
44. Gao F., Wei Z., An W., Wang K., Lu W. The interactomes of POU5F1 and SOX2 enhancers in human embryonic stem cells. Sci. Rep. 2013, 3:1588.
45. de Wit E., Bouwman B.A., Zhu Y., Klous P., Splinter E., Verstegen M.J., Krijger P.H., Festuccia N., Nora E.P., Welling M., Heard E., Geijsen N., Poot R.A., Chambers I., de Laat W. The pluripotent genome in three dimensions is shaped around pluripotency factors. Nature 2013, 501:227-231.
46. Phillips-Cremins J.E., Sauria M.E., Sanyal A., Gerasimova T.I., Lajoie B.R., Bell J.S., Ong C.T., Hookway T.A., Guo C., Sun Y., Bland M.J., Wagstaff W., Dalton S., McDevitt T.C., Sen R., Dekker J., Taylor J., Corces V.G. Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell 2013, 153:1281-1295.
47. Wei Z., Gao F., Kim S., Yang H., Lyu J., An W., Wang K., Lu W. Klf4 organizes long-range chromosomal interactions with the oct4 locus in reprogramming and pluripotency. Cell Stem Cell 2013, 13:36-47.
48. Zhang H., Jiao W., Sun L., Fan J., Chen M., Wang H., Xu X., Shen A., Li T., Niu B., Ge S., Li W., Cui J., Wang G., Sun J., Fan X., Hu X., Mrsny R.J., Hoffman A.R., Hu J.F. Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogramming. Cell Stem Cell 2013, 13:30-35.
49. Guo X., Tang Y. OCT4 pseudogenes present in human leukemia cells. Clin. Exp. Med. 2012, 12:207-216.
50. Kaltz N., Funari A., Hippauf S., Delorme B., Noel D., Riminucci M., Jacobs V.R., Haupl T., Jorgensen C., Charbord P., Peschel C., Bianco P., Oostendorp R.A. In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells 2008, 26:2419-2424.
51. Mueller T., Luetzkendorf J., Nerger K., Schmoll H.J., Mueller L.P. Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells. Cell. Mol. Life Sci. 2009, 66:495-503.
52. Pain D., Chirn G.W., Strassel C., Kemp D.M. Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. J. Biol. Chem. 2005, 280:6265-6268.
53. Redshaw Z., Strain A.J. Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression. J. Negat. Results Biomed. 2010, 9:2.
54. Suo G., Han J., Wang X., Zhang J., Zhao Y., Dai J. Oct4 pseudogenes are transcribed in cancers. Biochem. Biophys. Res. Commun. 2005, 337:1047-1051.
55. Liedtke S., Enczmann J., Waclawczyk S., Wernet P., Kogler G. Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 2007, 1:364-366.
56. Kalyana-Sundaram S., Kumar-Sinha C., Shankar S., Robinson D.R., Wu Y.M., Cao X., Asangani I.A., Kothari V., Prensner J.R., Lonigro R.J., Iyer M.K., Barrette T., Shanmugam A., Dhanasekaran S.M., Palanisamy N., Chinnaiyan A.M. Expressed pseudogenes in the transcriptional landscape of human cancers. Cell 2012, 149:1622-1634.
57. Palmieri S.L., Peter W., Hess H., Schöler H.R. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev. Biol. 1994, 166:259-267.
58. Nichols J., Davidson D., Taga T., Yoshida K., Chambers I., Smith A. Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis. Mech. Dev. 1996, 57:123-131.
59. Foygel K., Choi B., Jun S., Leong D.E., Lee A., Wong C.C., Zuo E., Eckart M., Reijo Pera R.A., Wong W.H., Yao M.W. A novel and critical role for Oct4 as a regulator of the maternal-embryonic transition. PLoS One 2008, 3:e4109.
60. Tan M.H., Au K.F., Leong D.E., Foygel K., Wong W.H., Yao M.W. An Oct4-Sall4-Nanog network controls developmental progression in the pre-implantation mouse embryo. Mol. Syst. Biol. 2013, 9:632.
61. Leichsenring M., Maes J., Mossner R., Driever W., Onichtchouk D. Pou5f1 transcription factor controls zygotic gene activation in vertebrates. Science 2013, 341:1005-1009.
62. Lee M.T., Bonneau A.R., Takacs C.M., Bazzini A.A., Divito K.R., Fleming E.S., Giraldez A.J. Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition. Nature 2013, 10.1038/nature12632.
63. Wu G., Han D., Gong Y., Sebastiano V., Gentile L., Singhal N., Adachi K., Fischedick G., Ortmeier C., Sinn M., Radstaak M., Tomilin A., Schöler H.R. Establishment of totipotency does not depend on Oct4A. Nat. Cell Biol. 2013, 15:1089-1097.
64. Frum T., Halbisen M.A., Wang C., Amiri H., Robson P., Ralston A. Oct4 cell-autonomously promotes primitive endoderm development in the mouse blastocyst. Dev. Cell 2013, 25:610-622.
65. Carter M.G., Stagg C.A., Falco G., Yoshikawa T., Bassey U.C., Aiba K., Sharova L.V., Shaik N., Ko M.S. An in situ hybridization-based screen for heterogeneously expressed genes in mouse ES cells. Gene Expr. Patterns 2008, 8:181-198.
66. Chambers I., Silva J., Colby D., Nichols J., Nijmeijer B., Robertson M., Vrana J., Jones K., Grotewold L., Smith A. Nanog safeguards pluripotency and mediates germline development. Nature 2007, 450:1230-1234.
67. Faddah D.A., Wang H., Cheng A.W., Katz Y., Buganim Y., Jaenisch R. Single-cell analysis reveals that expression of nanog is biallelic and equally variable as that of other pluripotency factors in mouse ESCs. Cell Stem Cell 2013, 13:23-29.
68. Toyooka Y., Shimosato D., Murakami K., Takahashi K., Niwa H. Identification and characterization of subpopulations in undifferentiated ES cell culture. Development 2008, 135:909-918.
69. Karwacki-Neisius V., Goke J., Osorno R., Halbritter F., Ng J.H., Weisse A.Y., Wong F.C., Gagliardi A., Mullin N.P., Festuccia N., Colby D., Tomlinson S.R., Ng H.H., Chambers I. Reduced oct4 expression directs a robust pluripotent state with distinct signaling activity and increased enhancer occupancy by oct4 and nanog. Cell Stem Cell 2013, 12:531-545.
70. Radzisheuskaya A., Le Bin Chia G., Dos Santos R.L., Theunissen T.W., Castro L.F., Nichols J., Silva J.C. A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages. Nat. Cell Biol. 2013, 15(6):579-590.
71. Ding L., Paszkowski-Rogacz M., Nitzsche A., Slabicki M.M., Heninger A.K., de Vries I., Kittler R., Junqueira M., Shevchenko A., Schulz H., Hubner N., Doss M.X., Sachinidis A., Hescheler J., Iacone R., Anastassiadis K., Stewart A.F., Pisabarro M.T., Caldarelli A., Poser I., Theis M., Buchholz F. A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. Cell Stem Cell 2009, 4:403-415.
72. Zhang J., Tam W.L., Tong G.Q., Wu Q., Chan H.Y., Soh B.S., Lou Y., Yang J., Ma Y., Chai L., Ng H.H., Lufkin T., Robson P., Lim B. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat. Cell Biol. 2006, 8:1114-1123.
73. Zhang X., Zhang J., Wang T., Esteban M.A., Pei D. Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells. J. Biol. Chem. 2008, 283:35825-35833.
74. Deshpande A.M., Dai Y.S., Kim Y., Kim J., Kimlin L., Gao K., Wong D.T. Cdk2ap1 is required for epigenetic silencing of Oct4 during murine embryonic stem cell differentiation. J. Biol. Chem. 2009, 284:6043-6047.
75. Moreno-Manzano V., Rodriguez-Jimenez F.J., Acena-Bonilla J.L., Fustero-Lardies S., Erceg S., Dopazo J., Montaner D., Stojkovic M., Sanchez-Puelles J.M. FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status. J. Biol. Chem. 2010, 285:1333-1342.
76. Tam W.L., Lim C.Y., Han J., Zhang J., Ang Y.S., Ng H.H., Yang H., Lim B. T-cell factor 3 regulates embryonic stem cell pluripotency and self-renewal by the transcriptional control of multiple lineage pathways. Stem Cells 2008, 26:2019-2031.
77. Jaenisch R., Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008, 132:567-582.
78. Young R.A. Control of the embryonic stem cell state. Cell 2011, 144:940-954.
79. Festuccia N., Osorno R., Halbritter F., Karwacki-Neisius V., Navarro P., Colby D., Wong F., Yates A., Tomlinson S.R., Chambers I. Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell 2012, 11:477-490.
80. Galan-Caridad J.M., Harel S., Arenzana T.L., Hou Z.E., Doetsch F.K., Mirny L.A., Reizis B. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell 2007, 129:345-357.
81. Han J., Yuan P., Yang H., Zhang J., Soh B.S., Li P., Lim S.L., Cao S., Tay J., Orlov Y.L., Lufkin T., Ng H.H., Tam W.L., Lim B. Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature 2010, 463:1096-1100.
82. Ivanova N., Dobrin R., Lu R., Kotenko I., Levorse J., DeCoste C., Schafer X., Lun Y., Lemischka I.R. Dissecting self-renewal in stem cells with RNA interference. Nature 2006, 442:533-538.
83. Jia J., Zheng X., Hu G., Cui K., Zhang J., Zhang A., Jiang H., Lu B., Yates J., Liu C., Zhao K., Zheng Y. Regulation of pluripotency and self-renewal of ESCs through epigenetic-threshold modulation and mRNA pruning. Cell 2012, 151:576-589.
84. Jiang J., Chan Y.S., Loh Y.H., Cai J., Tong G.Q., Lim C.A., Robson P., Zhong S., Ng H.H. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. Cell Biol. 2008, 10:353-360.
85. Lim C.Y., Tam W.L., Zhang J., Ang H.S., Jia H., Lipovich L., Ng H.H., Wei C.L., Sung W.K., Robson P., Yang H., Lim B. Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. Cell Stem Cell 2008, 3:543-554.
86. Martello G., Sugimoto T., Diamanti E., Joshi A., Hannah R., Ohtsuka S., Gottgens B., Niwa H., Smith A. Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell 2012, 11:491-504.
87. Parisi S., Passaro F., Aloia L., Manabe I., Nagai R., Pastore L., Russo T. Klf5 is involved in self-renewal of mouse embryonic stem cells. J. Cell Sci. 2008, 121:2629-2634.
88. Yang J., Chai L., Fowles T.C., Alipio Z., Xu D., Fink L.M., Ward D.C., Ma Y. Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19756-19761.
89. Zhou Q., Chipperfield H., Melton D.A., Wong W.H. A gene regulatory network in mouse embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16438-16443.
90. Ambrosetti D.C., Schöler H.R., Dailey L., Basilico C. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J. Biol. Chem. 2000, 275:23387-23397.
91. Catena R., Tiveron C., Ronchi A., Porta S., Ferri A., Tatangelo L., Cavallaro M., Favaro R., Ottolenghi S., Reinbold R., Schöler H., Nicolis S.K. Conserved POU binding DNA sites in the Sox2 upstream enhancer regulate gene expression in embryonic and neural stem cells. J. Biol. Chem. 2004, 279:41846-41857.
92. Chew J.L., Loh Y.H., Zhang W., Chen X., Tam W.L., Yeap L.S., Li P., Ang Y.S., Lim B., Robson P., Ng H.H. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol. Cell. Biol. 2005, 25:6031-6046.
93. Kuroda T., Tada M., Kubota H., Kimura H., Hatano S.Y., Suemori H., Nakatsuji N., Tada T. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol. Cell. Biol. 2005, 25:2475-2485.
94. Okumura-Nakanishi S., Saito M., Niwa H., Ishikawa F. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J. Biol. Chem. 2005, 280:5307-5317.
95. Rodda D.J., Chew J.L., Lim L.H., Loh Y.H., Wang B., Ng H.H., Robson P. Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem. 2005, 280:24731-24737.
96. Shen-Orr S.S., Milo R., Mangan S., Alon U. Network motifs in the transcriptional regulation network of Escherichia coli. Nat. Genet. 2002, 31:64-68.
97. Xu N., Papagiannakopoulos T., Pan G., Thomson J.A., Kosik K.S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009, 137:647-658.
98. Marson A., Levine S.S., Cole M.F., Frampton G.M., Brambrink T., Johnstone S., Guenther M.G., Johnston W.K., Wernig M., Newman J., Calabrese J.M., Dennis L.M., Volkert T.L., Gupta S., Love J., Hannett N., Sharp P.A., Bartel D.P., Jaenisch R., Young R.A. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 2008, 134:521-533.
99. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., Jaenisch R., Wagschal A., Feil R., Schreiber S.L., Lander E.S. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
100. Do D.V., Ueda J., Messerschmidt D.M., Lorthongpanich C., Zhou Y., Feng B., Guo G., Lin P.J., Hossain M.Z., Zhang W., Moh A., Wu Q., Robson P., Ng H.H., Poellinger L., Knowles B.B., Solter D., Fu X.Y. A genetic and developmental pathway from STAT3 to the OCT4-NANOG circuit is essential for maintenance of ICM lineages in vivo. Genes Dev. 2013, 27:1378-1390.
101. Hall J., Guo G., Wray J., Eyres I., Nichols J., Grotewold L., Morfopoulou S., Humphreys P., Mansfield W., Walker R., Tomlinson S., Smith A. Oct4 and LIF/Stat3 additively induce Kruppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell 2009, 5:597-609.
102. Niwa H., Ogawa K., Shimosato D., Adachi K. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 2009, 460:118-122.
103. Ying Q.L., Nichols J., Chambers I., Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003, 115:281-292.
104. Ying Q.L., Wray J., Nichols J., Batlle-Morera L., Doble B., Woodgett J., Cohen P., Smith A. The ground state of embryonic stem cell self-renewal. Nature 2008, 453:519-523.
105. James D., Levine A.J., Besser D., Hemmati-Brivanlou A. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005, 132:1273-1282.
106. Vallier L., Alexander M., Pedersen R.A. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 2005, 118:4495-4509.
107. Xu R.H., Peck R.M., Li D.S., Feng X., Ludwig T., Thomson J.A. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods 2005, 2:185-190.
108. Strumpf D., Mao C.A., Yamanaka Y., Ralston A., Chawengsaksophak K., Beck F., Rossant J. Cdx2 is required for correct cell fate specification and differentiation of trophectoderm in the mouse blastocyst. Development 2005, 132:2093-2102.
109. Wu G., Gentile L., Fuchikami T., Sutter J., Psathaki K., Esteves T.C., Arauzo-Bravo M.J., Ortmeier C., Verberk G., Abe K., Schöler H.R. Initiation of trophectoderm lineage specification in mouse embryos is independent of Cdx2. Development 2010, 137:4159-4169.
110. Niwa H., Toyooka Y., Shimosato D., Strumpf D., Takahashi K., Yagi R., Rossant J. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 2005, 123:917-929.
111. Tolkunova E., Cavaleri F., Eckardt S., Reinbold R., Christenson L.K., Schöler H.R., Tomilin A. The caudal-related protein cdx2 promotes trophoblast differentiation of mouse embryonic stem cells. Stem Cells 2006, 24:139-144.
112. Wang K., Sengupta S., Magnani L., Wilson C.A., Henry R.W., Knott J.G. Brg1 is required for Cdx2-mediated repression of Oct4 expression in mouse blastocysts. PLoS One 2010, 5:e10622.
113. Yuan P., Han J., Guo G., Orlov Y.L., Huss M., Loh Y.H., Yaw L.P., Robson P., Lim B., Ng H.H. Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells. Genes Dev. 2009, 23:2507-2520.
114. Dietrich J.E., Hiiragi T. Stochastic patterning in the mouse pre-implantation embryo. Development 2007, 134:4219-4231.
115. Blij S., Frum T., Akyol A., Fearon E., Ralston A. Maternal Cdx2 is dispensable for mouse development. Development 2012, 139:3969-3972.
116. Ralston A., Cox B.J., Nishioka N., Sasaki H., Chea E., Rugg-Gunn P., Guo G., Robson P., Draper J.S., Rossant J. Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2. Development 2010, 137:395-403.
117. Avilion A.A., Nicolis S.K., Pevny L.H., Perez L., Vivian N., Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 2003, 17:126-140.
118. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113:631-642.
119. Yuan H., Corbi N., Basilico C., Dailey L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 1995, 9:2635-2645.
120. Chazaud C., Yamanaka Y., Pawson T., Rossant J. Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK pathway. Dev. Cell 2006, 10:615-624.
121. Guo G., Huss M., Tong G.Q., Wang C., Li Sun L., Clarke N.D., Robson P. Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst. Dev. Cell 2010, 18:675-685.
122. Kang M., Piliszek A., Artus J., Hadjantonakis A.K. FGF4 is required for lineage restriction and salt-and-pepper distribution of primitive endoderm factors but not their initial expression in the mouse. Development 2013, 140:267-279.
123. Nichols J., Silva J., Roode M., Smith A. Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development 2009, 136:3215-3222.
124. Yamanaka Y., Lanner F., Rossant J. FGF signal-dependent segregation of primitive endoderm and epiblast in the mouse blastocyst. Development 2010, 137:715-724.
125. Messerschmidt D.M., Kemler R. Nanog is required for primitive endoderm formation through a non-cell autonomous mechanism. Dev. Biol. 2010, 344:129-137.
126. Frankenberg S., Gerbe F., Bessonnard S., Belville C., Pouchin P., Bardot O., Chazaud C. Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. Dev. Cell 2011, 21:1005-1013.
127. Aksoy I., Jauch R., Chen J., Dyla M., Divakar U., Bogu G.K., Teo R., Leng Ng C.K., Herath W., Lili S., Hutchins A.P., Robson P., Kolatkar P.R., Stanton L.W. Oct4 switches partnering from Sox2 to Sox17 to reinterpret the enhancer code and specify endoderm. EMBO J. 2013, 32:938-953.
128. Downs K.M. Systematic localization of Oct-3/4 to the gastrulating mouse conceptus suggests manifold roles in mammalian development. Dev. Dyn. 2008, 237:464-475.
129. Shen X., Liu Y., Hsu Y.J., Fujiwara Y., Kim J., Mao X., Yuan G.C., Orkin S.H. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol. Cell 2008, 32:491-502.
130. Thomson M., Liu S.J., Zou L.N., Smith Z., Meissner A., Ramanathan S. Pluripotency factors in embryonic stem cells regulate differentiation into germ layers. Cell 2011, 145:875-889.
131. Teo A.K., Arnold S.J., Trotter M.W., Brown S., Ang L.T., Chng Z., Robertson E.J., Dunn N.R., Vallier L. Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev. 2011, 25:238-250.
132. Wang Z., Oron E., Nelson B., Razis S., Ivanova N. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell 2012, 10:440-454.
133. Osorno R., Tsakiridis A., Wong F., Cambray N., Economou C., Wilkie R., Blin G., Scotting P.J., Chambers I., Wilson V. The developmental dismantling of pluripotency is reversed by ectopic Oct4 expression. Development 2012, 139:2288-2298.
134. Feldman N., Gerson A., Fang J., Li E., Zhang Y., Shinkai Y., Cedar H., Bergman Y. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 2006, 8:188-194.
135. Athanasiadou R., de Sousa D., Myant K., Merusi C., Stancheva I., Bird A. Targeting of de novo DNA methylation throughout the Oct-4 gene regulatory region in differentiating embryonic stem cells. PLoS One 2010, 5:e9937.
136. Hattori N., Nishino K., Ko Y.G., Ohgane J., Tanaka S., Shiota K. Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J. Biol. Chem. 2004, 279:17063-17069.
137. Li J.Y., Pu M.T., Hirasawa R., Li B.Z., Huang Y.N., Zeng R., Jing N.H., Chen T., Li E., Sasaki H., Xu G.L. Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog. Mol. Cell. Biol. 2007, 27:8748-8759.
138. Ryan J.M., Pettit A.R., Guillot P.V., Chan J.K., Fisk N.M. Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of the emperor's new clothes. Stem Cell Rev. 2013, 9:408-421.
139. Tai M.H., Chang C.C., Kiupel M., Webster J.D., Olson L.K., Trosko J.E. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005, 26:495-502.
140. Zangrossi S., Marabese M., Broggini M., Giordano R., D'Erasmo M., Montelatici E., Intini D., Neri A., Pesce M., Rebulla P., Lazzari L. Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells 2007, 25:1675-1680.
141. Lengner C.J., Camargo F.D., Hochedlinger K., Welstead G.G., Zaidi S., Gokhale S., Schöler H.R., Tomilin A., Jaenisch R. Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 2007, 1:403-415.
142. Cheng L., Sung M.T., Cossu-Rocca P., Jones T.D., MacLennan G.T., De Jong J., Lopez-Beltran A., Montironi R., Looijenga L.H. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J. Pathol. 2007, 211:1-9.
143. Yamaguchi S., Yamazaki Y., Ishikawa Y., Kawaguchi N., Mukai H., Nakamura T. EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12). Genes Chromosomes Cancer 2005, 43:217-222.
144. Hochedlinger K., Yamada Y., Beard C., Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005, 121:465-477.
145. Cantz T., Key G., Bleidissel M., Gentile L., Han D.W., Brenne A., Schöler H.R. Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 2008, 26:692-697.
146. Lengner C.J., Welstead G.G., Jaenisch R. The pluripotency regulator Oct4: a role in somatic stem cells?. Cell Cycle 2008, 7:725-728.
147. Liedtke S., Stephan M., Kogler G. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol. Chem. 2008, 389:845-850.
148. Wang X., Dai J. Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem Cells 2010, 28:885-893.
149. Adachi K., Schöler H.R. Directing reprogramming to pluripotency by transcription factors. Curr. Opin. Genet. Dev. 2012, 22:416-422.
150. Papp B., Plath K. Epigenetics of reprogramming to induced pluripotency. Cell 2013, 152:1324-1343.
151. Buganim Y., Faddah D.A., Jaenisch R. Mechanisms and models of somatic cell reprogramming. Nat. Rev. Genet. 2013, 14:427-439.
152. Stadtfeld M., Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev. 2010, 24:2239-2263.
153. Gonzalez F., Boue S., Izpisua Belmonte J.C. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat. Rev. Genet. 2011, 12:231-242.
154. Esteban M.A., Wang T., Qin B., Yang J., Qin D., Cai J., Li W., Weng Z., Chen J., Ni S., Chen K., Li Y., Liu X., Xu J., Zhang S., Li F., He W., Labuda K., Song Y., Peterbauer A., Wolbank S., Redl H., Zhong M., Cai D., Zeng L., Pei D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010, 6:71-79.
155. Hanna J., Saha K., Pando B., van Zon J., Lengner C.J., Creyghton M.P., van Oudenaarden A., Jaenisch R. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009, 462:595-601.
156. Pijnappel W.W., Esch D., Baltissen M.P., Wu G., Mischerikow N., Bergsma A.J., van der Wal E., Han D.W., Bruch H., Moritz S., Lijnzaad P., Altelaar A.F., Sameith K., Zaehres H., Heck A.J., Holstege F.C., Schöler H.R., Timmers H.T. A central role for TFIID in the pluripotent transcription circuitry. Nature 2013, 495:516-519.
157. Wernig M., Lengner C.J., Hanna J., Lodato M.A., Steine E., Foreman R., Staerk J., Markoulaki S., Jaenisch R. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 2008, 26:916-924.
158. Liang G., He J., Zhang Y. Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Nat. Cell Biol. 2012, 14:457-466.
159. Liu X., Sun H., Qi J., Wang L., He S., Liu J., Feng C., Chen C., Li W., Guo Y., Qin D., Pan G., Chen J., Pei D., Zheng H. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Nat. Cell Biol. 2013, 15:829-838.
160. Mikkelsen T.S., Hanna J., Zhang X., Ku M., Wernig M., Schorderet P., Bernstein B.E., Jaenisch R., Lander E.S., Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454:49-55.
161. Onder T.T., Kara N., Cherry A., Sinha A.U., Zhu N., Bernt K.M., Cahan P., Marcarci B.O., Unternaehrer J., Gupta P.B., Lander E.S., Armstrong S.A., Daley G.Q. Chromatin-modifying enzymes as modulators of reprogramming. Nature 2012, 483:598-602.
162. Wang T., Chen K., Zeng X., Yang J., Wu Y., Shi X., Qin B., Zeng L., Esteban M.A., Pan G., Pei D. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 2011, 9:575-587.
163. Rais Y., Zviran A., Geula S., Gafni O., Chomsky E., Viukov S., Mansour A.A., Caspi I., Krupalnik V., Zerbib M., Maza I., Mor N., Baran D., Weinberger L., Jaitin D.A., Lara-Astiaso D., Blecher-Gonen R., Shipony Z., Mukamel Z., Hagai T., Gilad S., Amann-Zalcenstein D., Tanay A., Amit I., Novershtern N., Hanna J.H. Deterministic direct reprogramming of somatic cells to pluripotency. Nature 2013, 502:65-70.
164. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., Okita K., Mochiduki Y., Takizawa N., Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 2008, 26:101-106.
165. Greder L.V., Gupta S., Li S., Abedin M.J., Sajini A., Segal Y., Slack J.M., Dutton J.R. Analysis of endogenous Oct4 activation during induced pluripotent stem cell reprogramming using an inducible Oct4 lineage label. Stem Cells 2012, 30:2596-2601.
166. Feng B., Jiang J., Kraus P., Ng J.H., Heng J.C., Chan Y.S., Yaw L.P., Zhang W., Loh Y.H., Han J., Vega V.B., Cacheux-Rataboul V., Lim B., Lufkin T., Ng H.H. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat. Cell Biol. 2009, 11:197-203.
167. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
168. Kim J.B., Greber B., Arauzo-Bravo M.J., Meyer J., Park K.I., Zaehres H., Schöler H.R. Direct reprogramming of human neural stem cells by OCT4. Nature 2009, 461:649-653.
169. Kim J.B., Sebastiano V., Wu G., Arauzo-Bravo M.J., Sasse P., Gentile L., Ko K., Ruau D., Ehrich M., van den Boom D., Meyer J., Hubner K., Bernemann C., Ortmeier C., Zenke M., Fleischmann B.K., Zaehres H., Schöler H.R. Oct4-induced pluripotency in adult neural stem cells. Cell 2009, 136:411-419.
170. Li Y., Zhang Q., Yin X., Yang W., Du Y., Hou P., Ge J., Liu C., Zhang W., Zhang X., Wu Y., Li H., Liu K., Wu C., Song Z., Zhao Y., Shi Y., Deng H. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res. 2011, 21:196-204.
171. Yuan X., Wan H., Zhao X., Zhu S., Zhou Q., Ding S. Combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts. Stem Cells 2011, 29:549-553.
172. Heng J.C., Feng B., Han J., Jiang J., Kraus P., Ng J.H., Orlov Y.L., Huss M., Yang L., Lufkin T., Lim B., Ng H.H. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 2010, 6:167-174.
173. Gu P., Goodwin B., Chung A.C., Xu X., Wheeler D.A., Price R.R., Galardi C., Peng L., Latour A.M., Koller B.H., Gossen J., Kliewer S.A., Cooney A.J. Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development. Mol. Cell. Biol. 2005, 25:3492-3505.
174. Sterneckert J., Hoing S., Schöler H.R. Concise review: Oct4 and more: the reprogramming expressway. Stem Cells 2012, 30:15-21.
175. Gao Y., Chen J., Li K., Wu T., Huang B., Liu W., Kou X., Zhang Y., Huang H., Jiang Y., Yao C., Liu X., Lu Z., Xu Z., Kang L., Wang H., Cai T., Gao S. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell 2013, 12:453-469.
176. Moon J.H., Yun W., Kim J., Hyeon S., Kang P.J., Park G., Kim A., Oh S., Whang K.Y., Kim D.W., Yoon B.S., You S. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog. Biochem. Biophys. Res. Commun. 2013, 431:444-449.
177. Buganim Y., Faddah D.A., Cheng A.W., Itskovich E., Markoulaki S., Ganz K., Klemm S.L., van Oudenaarden A., Jaenisch R. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 2012, 150:1209-1222.
178. Montserrat N., Nivet E., Sancho-Martinez I., Hishida T., Kumar S., Miquel L., Cortina C., Hishida Y., Xia Y., Esteban C.R., Izpisua Belmonte J.C. Reprogramming of human fibroblasts to pluripotency with lineage specifiers. Cell Stem Cell 2013, 13:341-350.
179. Shu J., Wu C., Wu Y., Li Z., Shao S., Zhao W., Tang X., Yang H., Shen L., Zuo X., Yang W., Shi Y., Chi X., Zhang H., Gao G., Shu Y., Yuan K., He W., Tang C., Zhao Y., Deng H. Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell 2013, 153:963-975.
180. Samavarchi-Tehrani P., Golipour A., David L., Sung H.K., Beyer T.A., Datti A., Woltjen K., Nagy A., Wrana J.L. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010, 7:64-77.
181. Doege C.A., Inoue K., Yamashita T., Rhee D.B., Travis S., Fujita R., Guarnieri P., Bhagat G., Vanti W.B., Shih A., Levine R.L., Nik S., Chen E.I., Abeliovich A. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 2012, 488:652-655.
182. Koche R.P., Smith Z.D., Adli M., Gu H., Ku M., Gnirke A., Bernstein B.E., Meissner A. Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 2011, 8:96-105.
183. Taberlay P.C., Kelly T.K., Liu C.C., You J.S., De Carvalho D.D., Miranda T.B., Zhou X.J., Liang G., Jones P.A. Polycomb-repressed genes have permissive enhancers that initiate reprogramming. Cell 2011, 147:1283-1294.
184. You J.S., Kelly T.K., De Carvalho D.D., Taberlay P.C., Liang G., Jones P.A. OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:14497-14502.
185. Polo J.M., Anderssen E., Walsh R.M., Schwarz B.A., Nefzger C.M., Lim S.M., Borkent M., Apostolou E., Alaei S., Cloutier J., Bar-Nur O., Cheloufi S., Stadtfeld M., Figueroa M.E., Robinton D., Natesan S., Melnick A., Zhu J., Ramaswamy S., Hochedlinger K. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012, 151:1617-1632.
186. Hansson J., Rafiee M.R., Reiland S., Polo J.M., Gehring J., Okawa S., Huber W., Hochedlinger K., Krijgsveld J. Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency. Cell Rep. 2012, 2:1579-1592.
187. Golipour A., David L., Liu Y., Jayakumaran G., Hirsch C.L., Trcka D., Wrana J.L. A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network. Cell Stem Cell 2012, 11:769-782.
188. Silva J., Nichols J., Theunissen T.W., Guo G., van Oosten A.L., Barrandon O., Wray J., Yamanaka S., Chambers I., Smith A. Nanog is the gateway to the pluripotent ground state. Cell 2009, 138:722-737.
189. Hou P., Li Y., Zhang X., Liu C., Guan J., Li H., Zhao T., Ye J., Yang W., Liu K., Ge J., Xu J., Zhang Q., Zhao Y., Deng H. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013, 341:651-654.
190. Sturm R.A., Herr W. The POU domain is a bipartite DNA-binding structure. Nature 1988, 336:601-604.
191. Frankenberg S., Pask A., Renfree M.B. The evolution of class V POU domain transcription factors in vertebrates and their characterisation in a marsupial. Dev. Biol. 2010, 337:162-170.
192. Tapia N., Reinhardt P., Duemmler A., Wu G., Arauzo-Bravo M.J., Esch D., Greber B., Cojocaru V., Rascon C.A., Tazaki A., Kump K., Voss R., Tanaka E.M., Schöler H.R. Reprogramming to pluripotency is an ancient trait of vertebrate Oct4 and Pou2 proteins. Nat. Commun. 2012, 3:1279.
193. Niwa H., Sekita Y., Tsend-Ayush E., Grutzner F. Platypus Pou5f1 reveals the first steps in the evolution of trophectoderm differentiation and pluripotency in mammals. Evol. Dev. 2008, 10:671-682.
194. Phillips K., Luisi B. The virtuoso of versatility: POU proteins that flex to fit. J. Mol. Biol. 2000, 302:1023-1039.
195. Verrijzer C.P., Alkema M.J., van Weperen W.W., Van Leeuwen H.C., Strating M.J., van der Vliet P.C. The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J. 1992, 11:4993-5003.
196. Aurora R., Herr W. Segments of the POU domain influence one another's DNA-binding specificity. Mol. Cell. Biol. 1992, 12:455-467.
197. Klemm J.D., Pabo C.O. Oct-1 POU domain-DNA interactions: cooperative binding of isolated subdomains and effects of covalent linkage. Genes Dev. 1996, 10:27-36.
198. Jacobson E.M., Li P., Leon-del-Rio A., Rosenfeld M.G., Aggarwal A.K. Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. Genes Dev. 1997, 11:198-212.
199. Rhee J.M., Gruber C.A., Brodie T.B., Trieu M., Turner E.E. Highly cooperative homodimerization is a conserved property of neural POU proteins. J. Biol. Chem. 1998, 273:34196-34205.
200. Scully K.M., Jacobson E.M., Jepsen K., Lunyak V., Viadiu H., Carriere C., Rose D.W., Hooshmand F., Aggarwal A.K., Rosenfeld M.G. Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 2000, 290:1127-1131.
201. Tomilin A., Remenyi A., Lins K., Bak H., Leidel S., Vriend G., Wilmanns M., Schöler H.R. Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration. Cell 2000, 103:853-864.
202. Sharov A.A., Ko M.S. Exhaustive search for over-represented DNA sequence motifs with CisFinder. DNA Res. 2009, 16:261-273.
203. Chasman D., Cepek K., Sharp P.A., Pabo C.O. Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex: specific recognition of a protein-DNA interface. Genes Dev. 1999, 13:2650-2657.
204. Jauch R., Choo S.H., Ng C.K., Kolatkar P.R. Crystal structure of the dimeric Oct6 (POU3f1) POU domain bound to palindromic MORE DNA. Proteins 2011, 79:674-677.
205. Klemm J.D., Rould M.A., Aurora R., Herr W., Pabo C.O. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 1994, 77:21-32.
206. Pereira J.H., Kim S.H. Structure of human Brn-5 transcription factor in complex with CRH gene promoter. J. Struct. Biol. 2009, 167:159-165.
207. Remenyi A., Lins K., Nissen L.J., Reinbold R., Schöler H.R., Wilmanns M. Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Genes Dev. 2003, 17:2048-2059.
208. Remenyi A., Tomilin A., Pohl E., Lins K., Philippsen A., Reinbold R., Schöler H.R., Wilmanns M. Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Mol. Cell 2001, 8:569-580.
209. Williams D.C., Cai M., Clore G.M. Molecular basis for synergistic transcriptional activation by Oct1 and Sox2 revealed from the solution structure of the 42-kDa Oct1.Sox2.Hoxb1-DNA ternary transcription factor complex. J. Biol. Chem. 2004, 279:1449-1457.
210. Brehm A., Ohbo K., Schöler H. The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol. Cell. Biol. 1997, 17:154-162.
211. Niwa H., Masui S., Chambers I., Smith A.G., Miyazaki J. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol. Cell. Biol. 2002, 22:1526-1536.
212. Hammachi F., Morrison G.M., Sharov A.A., Livigni A., Narayan S., Papapetrou E.P., O'Malley J., Kaji K., Ko M.S., Ptashne M., Brickman J.M. Transcriptional activation by Oct4 is sufficient for the maintenance and induction of pluripotency. Cell Rep. 2012, 1:99-109.
213. Nishimoto M., Miyagi S., Yamagishi T., Sakaguchi T., Niwa H., Muramatsu M., Okuda A. Oct-3/4 maintains the proliferative embryonic stem cell state via specific binding to a variant octamer sequence in the regulatory region of the UTF1 locus. Mol. Cell. Biol. 2005, 25:5084-5094.
214. Doucleff M., Clore G.M. Global jumping and domain-specific intersegment transfer between DNA cognate sites of the multidomain transcription factor Oct-1. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13871-13876.
215. Takayama Y., Clore G.M. Intra- and intermolecular translocation of the bi-domain transcription factor Oct1 characterized by liquid crystal and paramagnetic NMR. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:E169-E176.
216. Pan G., Qin B., Liu N., Schöler H.R., Pei D. Identification of a nuclear localization signal in OCT4 and generation of a dominant negative mutant by its ablation. J. Biol. Chem. 2004, 279:37013-37020.
217. van Leeuwen H.C., Strating M.J., Rensen M., de Laat W., van der Vliet P.C. Linker length and composition influence the flexibility of Oct-1 DNA binding. EMBO J. 1997, 16:2043-2053.
218. Toth-Petroczy A., Simon I., Fuxreiter M., Levy Y. Disordered tails of homeodomains facilitate DNA recognition by providing a trade-off between folding and specific binding. J. Am. Chem. Soc. 2009, 131:15084-15085.
219. Atlasi Y., Mowla S.J., Ziaee S.A., Gokhale P.J., Andrews P.W. OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 2008, 26:3068-3074.
220. Lee J., Kim H.K., Rho J.Y., Han Y.M., Kim J. The human OCT-4 isoforms differ in their ability to confer self-renewal. J. Biol. Chem. 2006, 281:33554-33565.
221. Wang X., Zhao Y., Xiao Z., Chen B., Wei Z., Wang B., Zhang J., Han J., Gao Y., Li L., Zhao H., Zhao W., Lin H., Dai J. Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response. Stem Cells 2009, 27:1265-1275.
222. Gao Y., Wei J., Han J., Wang X., Su G., Zhao Y., Chen B., Xiao Z., Cao J., Dai J. The novel function of OCT4B isoform-265 in genotoxic stress. Stem Cells 2012, 30:665-672.
223. Gao Y., Wang X., Han J., Xiao Z., Chen B., Su G., Dai J. The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B. J. Genet. Genomics 2010, 37:461-465.
224. Jang H., Kim T.W., Yoon S., Choi S.Y., Kang T.W., Kim S.Y., Kwon Y.W., Cho E.J., Youn H.D. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 2012, 11:62-74.
225. Brumbaugh J., Hou Z., Russell J.D., Howden S.E., Yu P., Ledvina A.R., Coon J.J., Thomson J.A. Phosphorylation regulates human OCT4. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:7162-7168.
226. Saxe J.P., Tomilin A., Schöler H.R., Plath K., Huang J. Post-translational regulation of Oct4 transcriptional activity. PLoS One 2009, 4:e4467.
227. Spelat R., Ferro F., Curcio F. Serine 111 phosphorylation regulates OCT4A protein subcellular distribution and degradation. J. Biol. Chem. 2012, 287:38279-38288.
228. Wei F., Schöler H.R., Atchison M.L. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J. Biol. Chem. 2007, 282:21551-21560.
229. Liao B., Jin Y. Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner. Cell Res. 2010, 20:332-344.
230. Lam C.S., Mistri T.K., Foo Y.H., Sudhaharan T., Gan H.T., Rodda D., Lim L.H., Chou C., Robson P., Wohland T., Ahmed S. DNA-dependent Oct4-Sox2 interaction and diffusion properties characteristic of the pluripotent cell state revealed by fluorescence spectroscopy. Biochem. J. 2012, 448:21-33.
231. Jauch R., Aksoy I., Hutchins A.P., Ng C.K., Tian X.F., Chen J., Palasingam P., Robson P., Stanton L.W., Kolatkar P.R. Conversion of Sox17 into a pluripotency reprogramming factor by reengineering its association with Oct4 on DNA. Stem Cells 2011, 29:940-951.
232. Ng C.K., Li N.X., Chee S., Prabhakar S., Kolatkar P.R., Jauch R. Deciphering the Sox-Oct partner code by quantitative cooperativity measurements. Nucleic Acids Res. 2012, 40:4933-4941.
233. Ferraris L., Stewart A.P., Kang J., DeSimone A.M., Gemberling M., Tantin D., Fairbrother W.G. Combinatorial binding of transcription factors in the pluripotency control regions of the genome. Genome Res. 2011, 21:1055-1064.
234. Zhang X., Yalcin S., Lee D.F., Yeh T.Y., Lee S.M., Su J., Mungamuri S.K., Rimmele P., Kennedy M., Sellers R., Landthaler M., Tuschl T., Chi N.W., Lemischka I., Keller G., Ghaffari S. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat. Cell Biol. 2011, 13:1092-1099.
235. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 2011, 25:2227-2241.
236. Teif V.B., Vainshtein Y., Caudron-Herger M., Mallm J.P., Marth C., Hofer T., Rippe K. Genome-wide nucleosome positioning during embryonic stem cell development. Nat. Struct. Mol. Biol. 2012, 19:1185-1192.
237. Tan Y., Xue Y., Song C., Grunstein M. Acetylated histone H3K56 interacts with Oct4 to promote mouse embryonic stem cell pluripotency. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:11493-11498.
238. Liang J., Wan M., Zhang Y., Gu P., Xin H., Jung S.Y., Qin J., Wong J., Cooney A.J., Liu D., Songyang Z. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 2008, 10:731-739.
239. Wang J., Rao S., Chu J., Shen X., Levasseur D.N., Theunissen T.W., Orkin S.H. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006, 444:364-368.
240. Whyte W.A., Orlando D.A., Hnisz D., Abraham B.J., Lin C.Y., Kagey M.H., Rahl P.B., Lee T.I., Young R.A. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153:307-319.
241. Ho L., Miller E.L., Ronan J.L., Ho W.Q., Jothi R., Crabtree G.R. esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function. Nat. Cell Biol. 2011, 13:903-913.
242. Mansour A.A., Gafni O., Weinberger L., Zviran A., Ayyash M., Rais Y., Krupalnik V., Zerbib M., Amann-Zalcenstein D., Maza I., Geula S., Viukov S., Holtzman L., Pribluda A., Canaani E., Horn-Saban S., Amit I., Novershtern N., Hanna J.H. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Nature 2012, 488:409-413.
243. Ang Y.S., Tsai S.Y., Lee D.F., Monk J., Su J., Ratnakumar K., Ding J., Ge Y., Darr H., Chang B., Wang J., Rendl M., Bernstein E., Schaniel C., Lemischka I.R. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 2011, 145:183-197.
244. Faunes F., Hayward P., Descalzo S.M., Chatterjee S.S., Balayo T., Trott J., Christoforou A., Ferrer-Vaquer A., Hadjantonakis A.K., Dasgupta R., Arias A.M. A membrane-associated beta-catenin/Oct4 complex correlates with ground-state pluripotency in mouse embryonic stem cells. Development 2013, 140:1171-1183.